Survivor clinic attendance among pediatric- and adolescent-aged survivors of childhood cancer.
Adolescent
Adult
Age of Onset
Ambulatory Care
/ psychology
Cancer Survivors
/ psychology
Child
Child, Preschool
Female
Humans
Infant
Long-Term Care
/ methods
Male
Neoplasm Recurrence, Local
/ epidemiology
Neoplasms
/ epidemiology
Patient Participation
/ psychology
Retrospective Studies
Survivorship
Transition to Adult Care
/ standards
Young Adult
Childhood cancer survivorship
Clinic attendance
Late effects surveillance
Long-term follow-up care
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
11
10
2018
accepted:
04
12
2018
pubmed:
19
12
2018
medline:
11
2
2020
entrez:
19
12
2018
Statut:
ppublish
Résumé
Childhood cancer survivors need regular, risk-adapted, long-term survivor care. This retrospective study describes the proportion of survivors seen for an initial survivor clinic visit within a large pediatric oncology program. Patients diagnosed with non-central nervous system childhood malignancies from 2007 to 2012 were followed from the time of survivor clinic eligibility (2 years following completion of therapy) through their initial survivor clinic visit or end of study. Demographic, cancer-related, and logistical factors related to clinic attendance were examined using Kaplan-Meier curves and Cox proportional regressions. Eligible survivors were 53.0% male, 51.5% non-Hispanic white, and 30.9% survivors of leukemia. Among the 866 eligible survivors for this study, 610 (70.4%) completed their initial visit. After controlling for sex and time eligible, survivors who received surgery only (aHR 0.04 (0.02, 0.08)) or radiation only (0.24 (0.15, 0.39)) and who had Medicaid (0.77 (0.64, 0.92)) were significantly less likely to have an initial visit as were those of black or other/mixed race and those who lived > 25 mi from the clinic (p < 0.01). Survivors aged 6-11 years or 12-17 years at eligibility were significantly more likely to complete an initial visit as compared to those aged 2-5 years (1.55 (1.24, 1.93) and 1.44 (1.14, 1.83), respectively). Nearly a third of survivors were not seen in a pediatric survivor clinic despite the importance of survivor care. These results identify populations at risk for not pursuing long-term survivorship care. Failure to transition to pediatric survivor care may lead to lifelong non-engagement and incorrect perceptions about future health.
Identifiants
pubmed: 30560348
doi: 10.1007/s11764-018-0727-3
pii: 10.1007/s11764-018-0727-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
56-65Références
Ann Intern Med. 2014 Jan 7;160(1):11-7
pubmed: 24573662
J Cancer Surviv. 2016 Aug;10(4):711-25
pubmed: 26833205
J Clin Oncol. 2008 Sep 20;26(27):4401-9
pubmed: 18802152
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
J Pediatr Oncol Nurs. 2014 Nov-Dec;31(6):339-49
pubmed: 25013005
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
J Cancer Surviv. 2018 Jun;12(3):277-290
pubmed: 29222704
J Clin Oncol. 2009 May 10;27(14):2308-18
pubmed: 19364948
J Cancer Surviv. 2013 Sep;7(3):275-82
pubmed: 23471729
Appl Clin Inform. 2017 Mar 15;8(1):250-264
pubmed: 28293684
J Cancer Surviv. 2016 Jun;10(3):505-13
pubmed: 26572903
J Cancer Educ. 2016 Sep;31(3):430-42
pubmed: 25948413
J Cancer Surviv. 2012 Jun;6(2):155-62
pubmed: 22170442
JAMA. 2013 Jun 12;309(22):2371-2381
pubmed: 23757085
J Clin Oncol. 2014 Apr 20;32(12):1218-27
pubmed: 24638000
Arch Dis Child. 2004 Apr;89(4):374-7
pubmed: 15033851
J Cancer Surviv. 2016 Aug;10(4):611-8
pubmed: 26868681
J Cancer Surviv. 2008 Dec;2(4):225-32
pubmed: 18787958
J Pediatr Hematol Oncol. 2017 Apr;39(3):167-173
pubmed: 28060114
J Adolesc Young Adult Oncol. 2017 Mar;6(1):74-82
pubmed: 27754726
J Natl Cancer Inst. 2011 May 4;103(9):714-36
pubmed: 21454908
Cancer. 2011 May 1;117(9):1966-75
pubmed: 21509774
Health Serv Res. 2015 Aug;50(4):1021-42
pubmed: 25600956